First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study

Alessandro Di Federico, Kaiwen Wang, Monica F. Chen, Adam Barsouk, Arianna Pagliaro, L. Chen, Francesca Rita Ogliari, Paul Stockhammer, Rajat Thawani, Shahm Raslan, Eleonora Gariazzo, Francesca Fusco, Grace Hambelton, Fabrizio Citarella, David Meyer, Mihaela Aldea, Andrea De Giglio, Joao V. Alessi, Federica Pecci, Francesco Gelsomino, Marcelo Corassa, Natalie I. Vokes, Xinan Wang, Dario de Biase, Fawzi Abu Rous, Phurin Areesawangkit, Omar Elghawy, Alessio Cortellini, Giulio Metro, Roberto Ferrara, Mark M. Awad, Aliyah Pabani, Joseph C. Murray, Federico Cappuzzo, Marina Chiara Garassino, Ibiayi Dagogo‐Jack, Gregory J. Riely, Michael J. Grant, Benjamin Herzberg, Andrea Ardizzoni, David Planchard, Bruce E. Johnson, Corey J. Langer, Michael Offin, Marcelo V. Negrão, Biagio Ricciuti